Status:
COMPLETED
Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
Lead Sponsor:
David Garcia-Dorado
Collaborating Sponsors:
Hospital General Universitario Gregorio Marañon
Hospital Clínico Universitario de Valladolid
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO applied at the time of reperfusion to limit infarct size and LV remodelling in patients with ACSST submitted to ...
Detailed Description
The main mechanism responsible for the sanitary impact of ischemic heart disease is cardiomyocyte cell death associated to acute coronary syndrome with ST segment elevation (ACSST). In most of these p...
Eligibility Criteria
Inclusion
- patients older than 18 years.
- patients with acute coronary syndrome with ST segment elevation within six hours of the onset of symptoms.
Exclusion
- patients younger than 18 years and pregnant women.
- patients with previous transmural infarction.
- patients with clinical evidence of bronchospastic lung disease or prior bronchodilator therapy.
- patients with pacemakers.
- patients with TIMI flow higher than 1 and lower than 3.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00781404
Start Date
October 1 2008
End Date
July 1 2012
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ValldHebron Hospital
Barcelona, Barcelona, Spain, 08035